Research Article: IL6 receptor inhibitors: exploring the therapeutic potential across multiple diseases through drug target Mendelian randomization
Abstract:
Background: High interleukin-6 levels correlate with diseases like cancer, autoimmune disorders, and infections. IL-6 receptor inhibitors (IL-6Ri), used for rheumatoid arthritis and COVID-19, may have wider uses. We apply drug-target Mendelian Randomization (MR) to study IL-6Ri’s effects.
No summary available.